Atazanavir is a key protease inhibitor used in combination HIV therapy to suppress viral load and preserve immune function. It's known for once-daily dosing, low side effect burden, and effectiveness in first-line treatment when paired with NRTIs like tenofovir and emtricitabine.
Details
